Amendment 1 RFP 75N93023R00017.pdf
PDF 143 KB Posted
- Attached to
- Virology Core Laboratory Federal contract opportunity
- Solicitation number
- 75N93023R00017
About this file
This amendment to Request for Proposals 75N93023R00017 provides responses to potential offerors' questions about the virology core laboratory solicitation. The National Institute of Allergy and Infectious Diseases requires a contractor to generate one viral stock per year and conduct quality control assays for three months of short-term storage. Offerors should budget for annual shipping of viral stocks in accordance with requirements for maintaining viability. A minimum concentration of 1x106 RNA copies per mL is expected per vial. The amendment clarifies that included travel costs should be for consultants and collaborators, not government employees. The proposal due date of December 7, 2023 at 3:00 PM EST is unchanged.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Amendment 2 RFP 75N93023R00017.pdf | ||
| RFP 75N93023R00017.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
AMENDMENT #1 RFP No. 75N93023R00017 1
Amendment No. 1 RFP No. 75N93023R00017
“Virology Core Laboratory”
Solicitation Number: 75N93023R00017
Amendment Number: One (1)
Amendment Issue Date: October 30, 2023
Proposal Due Date/Time: December 7, 2023, at 3:00 PM, EST (Unchanged)
Issued By: Callie Prassinos
Contracting Officer
OA/DEA/NIAID/NIH/DHHS
5601 Fishers Lane, Room 3C21, MSC 9821 Bethesda, Maryland 20892-9821
Points of Contact: PRIMARY Kimberly.dormer@nih.gov Kim Dormer, Contract Specialist Phone: 301-761-6391
Please note that we do NOT intend to extend the due date for submission of proposals as a result of this amendment. The date specified for receipt of proposals remains unchanged.
Offerors must acknowledge receipt of this Amendment by identifying the amendment number and the date of the amendment on each copy of the submitted proposal. Failure to receive your acknowledgement may result in the rejection of your proposal. Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.
The purpose of this Amendment is to provide responses to questions from potential offerors, regarding the solicitation.
RESPONSES TO QUESTIONS FROM POTENTIAL OFFERORS:
1. How long are stock samples kept onsite before sending for long-term storage? Should cost of short term storage be included in cost?
Response: Plan on 3 months of short-term storage while QC assays are being conducted on viral stocks.
mailto:Kimberly.dormer@nih.gov
AMENDMENT #1 RFP No. 75N93023R00017 2
2. Will shipping of stock be ongoing or once per year?
Response: Yes, budget for shipping each year. Ensure each shipment follows requirements to maintain maximum viability of the virus stock.
3. How many viral stocks are expected per year?
Response: It is anticipated that 1 viral stock is generated each year. See Attachment 5, Section 3 (a).
4. What is the expected concentration per vial?
Response: A minimum of 1x106 RNA copies per mL concentration is expected.
5. The RFP business assumptions states to include cost of NIH personnel for onsite visit – in other contracts, NIH has covered their own travel costs. Do we include travel for government personnel in our travel budget?
Response: This cost assumption was not meant for Government employees, but other individuals associated with the Contract, such as Consultants or collaborating Principal Investigators.
END OF AMENDMENT NO. 1, RFP No. 75N93023R00017
File details come from the government source that posted it. Updated .